News
Rare cancer: key feature aids diagnosis and therapy for a specific form of nerve sheath tumor
Nerve sheath tumors are not only rare but also diverse and often difficult to treat. Using molecular...
NCT Trial Center – Newsletter July 2019
Topics of the NCT Trial Center´s newsletter in July 2019 are: Results of the Vorinostat study in...
The National Center for Tumour Diseases (NCT) Heidelberg, in cooperation with the German Cancer...
Scientists have evaluated the data from more than five million Swedish women to find out at what age...
5,579 runners took part in the 8th NCT charity run to take a stand against cancer and to collect...
Joint press release of the Uniklinik RWTH Aachen and NCT Heidelberg.
Chordomas are rare bone tumors for which only few options of treatment exist. Scientists and doctors...
Joint press release of the German Cancer Research Center and the University Hospital Heidelberg
Colorectal cancer is the third most common form of cancer worldwide and is one of the most common...
Resolution on molecular tumor boards (MTB)
The Directorate of NCT Heidelberg enacts guidelines for the organization of molecular tumor boards...